Co-Authors
This is a "connection" page, showing publications co-authored by LAURA BOVER and SATTVA S NEELAPU.
Connection Strength
0.516
-
Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas. J Immunother Cancer. 2023 11 24; 11(11).
Score: 0.243
-
Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma. Int J Cancer. 2014 Dec 15; 135(12):2834-46.
Score: 0.126
-
B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade. Front Immunol. 2022; 13:794684.
Score: 0.055
-
CD303 (BDCA-2) - a potential novel target for therapy in hematologic malignancies. Leuk Lymphoma. 2022 01; 63(1):19-30.
Score: 0.052
-
Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies In Vivo. Clin Cancer Res. 2018 03 01; 24(5):1114-1123.
Score: 0.040